US 10765691
Method for treating crohn's disease using triple antimicrobial all-in-one formulation
granted A61KA61K31/395A61K31/435
Quick answer
US patent 10765691 (Method for treating crohn's disease using triple antimicrobial all-in-one formulation) held by RedHill Biopharma Ltd. expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RedHill Biopharma Ltd.
- Grant date
- Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/395, A61K31/435, A61K31/438, A61K31/44